The 35th edition of the Telethon continues on Saturday. According to AFM-Telethon Scientific Director, the donations collected since the creation of the event have made it possible in particular to bring out new technologies that are useful in the fight against Covid-19.
Posted
Reading time : 1 min.
“One of the explanations why RNA vaccines against Covid-19 arrived quickly is because they were able to rely on research that has been carried out for more than twenty years on rare diseases”, said Serge Braun, scientific director of the AFM-Telethon, on Saturday December 4 on franceinfo, on the second day of the 35th edition of the Telethon. The marathon to raise donations for research to fight rare diseases continues this weekend.
“There are currently about fifteen drugs, registered and recognized by European or American agencies, mainly for rare diseases and it is these technologies that have enabled these vaccines to emerge”added Serge Braun.
# Telethon2021 : we have just reset the counter to zero! We have 30 hours to show our solidarity
and turn that counter into wins! The revolution in medicine is underway, thanks to you!Donate Now https://t.co/G8kAfgKTmd pic.twitter.com/zxnyEkHGeE
– AFM-Telethon (@Telethon_France) December 3, 2021
“Since the first Telethon, almost a billion and a half euros have been invested in research”, said the scientific director of AFM-Telethon. “One and a half billion euros is a huge sum”, but according to him “that’s roughly what it takes to develop a drug”. “Thanks to the Telethon, we have enabled the development of dozens of drugs”, he said on franceinfo. You can make a donation via the telephone platform 36 37 and on afm-telethon.fr.